Provention bio announces the grant of inducement awards

Red bank, n.j., june 2, 2021 /prnewswire/ -- provention bio, inc. (nasdaq: prvb) (the "company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that the company granted stock options to two new employees to purchase an aggregate of 40,000 shares of common stock.
PRVB Ratings Summary
PRVB Quant Ranking